ESR1 and breast cancer: Evidence that this finding might translate to human specimens of breast cancer tumors is provided by a study on a series of fresh breast cancers which showed that the MT1E isoform was highly expressed in estrogen receptor negative compared to estrogen receptor positive breast cancers [44].